Metacognition Assessment in Patient With Multiple Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-11

Study Completion Date

2022-04-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will assessed the level of consciousness of MS patients suffering of cognitive and motor disorders. Understanding the awareness of the disease is crucial to allow better management of these patients. It has been shown, for other neurological pathologies, that a lack of awareness of deficits leads to inefficient rehabilitation and a disorder of understanding the impact of deficits in daily activities. Metacognition could be altered with age, so we will include participants between 18 and 60 years old.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Social Cognition by Morphological and Functional Imaging in Multiple Sclerosis Patients

NCT02290587

Multiple Sclerosis

COMPLETED NA

Study of Empathy in MS

NCT05332951

Multiple Sclerosis

COMPLETED

Screening for Cognitive Disorders in Multiple Sclerosis

NCT07030036

Multiple Sclerosis Cognitive Dysfunction Neuropsychological Tests +1 more

NOT_YET_RECRUITING

Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant

NCT01392872

Multiple Sclerosis, Relapsing-Remitting

COMPLETED NA

Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple Sclerosis

NCT06303024

Multiple Sclerosis, Relapsing-Remitting

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subject who have to do neurological assessement by the Multiple sclerosis Functional Composite (MSFC) will be enrolled.

The patient will estimate the time to undergo the test. This time will be compared to the time really make by the patient to realise test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of multiple sclerosis
* Voluntary for participate to study

Exclusion Criteria

* Neurological disease other than Multiple Sclerosis
* psychiatric disease, other than depressiveness
* illicit substance abuse
* Persons referred to in Articles L1121-5 to 8 of the French Public Health Code

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No